Contact Us

marketing@medicilon.com

ABOUT

Company Profile

Corporate Culture

Management Team

Company History

Message from the CEO

Honors and Awards

SERVICES

SERVICES

01 Drug Discovery

Chemistry Research Biology Research Early Pharmacokinetics

02 Pharmaceutical Research

Intermediates Active Pharmaceutical Ingredients Pharmaceutical preparation Analytical Method Development and Quality Control CMC Filings Analytical Testing Center

03 Preclinical Research

Pharmacology & Pharmacodynamics Drug Safety Evaluation DMPK Bioanalysis IND Filings

PLATFORM

PLATFORM

01 One-stop Integrated Services

Liposome Drug Development Drug Discovery Pharmaceutical Research Preclinical Research Botanical Drug Preclinical R&D

02 Innovative Drug R&D Services

Peptide Drug Conjugate (PDC) Antibody Nucleic Acid Drug Cellular Immunotherapies mRNA Vaccine PROTAC ADC

03 Key Technical Services for Drug R&D

Cytokine and Biomarker Detection Metabolite Identification (MetID) Drug Forming Research Flow Cytometry Technology SEND Format Conversion Flow Sorting NanoString nCounter Detection Routes of Drug Administration

04 Drug Efficacy Evaluation for Common Diseases

Rodent Cerebrovascular Disease Inflammatory and Immune Diseases IO Pharmacodynamic Model

05 High-end Preparations Technology Platform

Skin Topical Preparation Ophthalmic drug Inhalation drug

06 Targeted Drugs R&D Services

STAT3-targeted Drugs R&D Service KRAS-targeted Drugs R&D Service GLP-1 New Drug R&D Service

07 Safety Assessment Lab of Process Chemistry

08 Public Services

CAREERS

Talent Development

Campus Recruitment

Recruitment

NEWS

Medicilon Events

Featured Stories

Market Events

Videos

A.C.E.

INVESTORS

Stock Information

Investment Contact

CLIENT CENTER

Intellectual Property Protection

Clients Testimonials

Downloads

Partnerships

Medicilon Support

Newsletters

CN

中

Medicilon Events

News and Events

Medicilon Events Featured Stories Market Events Videos A.C.E.

HomenewsMedicilon Events

Medicilon Events

Hot information：

Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon| Medicilon FTE services & FFS services - flexible and efficient cooperation model

Great news! Medicilon Analytical Testing Center has passed the CNAS on-site assessment!

Recently, the Analytical Testing Center of Shanghai Medicilon Inc. (Medicilon) successfully passed the on-site assessment by the China National Accreditation Service for Conformity Assessment (CNAS).

Great news! Medicilon Analytical Testing Center has passed the CNAS on-site assessment!

Medicilon Preclinical Research and Hetuo Innovation are joining hands to co-create and innovate in drug development

Medicilon announced that its wholly-owned subsidiary, Medicilon Preclinical Research (MRP), has officially signed a collaboration agreement with Hetuo Innovation (Hetuo) in the fields of neurological disorders, ophthalmic diseases, and cardiovascular system drugs.

Medicilon Preclinical Research and Hetuo Innovation are joining hands to co-create and innovate in drug development

Six consecutive years! Medicilon once again tops the '2023 China CXO Enterprise Top 20 List'

Medicilon, with its outstanding R&D capabilities and continuous spirit of innovation, has once again topped the 2023 China CXO (including CDMO) Enterprise Top 20 List. This is the sixth consecutive year that Medicilon has received this honor.

Six consecutive years! Medicilon once again tops the '2023 China CXO Enterprise Top 20 List'

For three consecutive years! Medicilon has been honored with the "Top Ten Drug Innovation Service Institutions of the Year" award at the 4th Pharmaceutical Innovation Awards.

Medicilon was honored with the "Top Ten Drug Innovation Service Institutions of the Year" at the 4th Pharmaceutical Innovation Awards for its innovative capabilities and service quality in the field of biopharmaceutical preclinical R&D services.

For three consecutive years! Medicilon has been honored with the "Top Ten Drug Innovation Service Institutions of the Year" award at the 4th Pharmaceutical Innovation Awards.

Medicilon assists Suzhou Jingye Medicine & Chemical in a strong transformation, listen to Weidong Yuan share how to open up a new chapter in the API field.

Suzhou Jingye successfully obtained the "Notice of Approval for Chemical API Marketing Application" issued by the NMPA for its raw material of Clomipramine hydrochloride. Meanwhile, as a partner of Jingye, Medicilon has provided services such as API process development and solvent substitution.

Medicilon assists Suzhou Jingye Medicine & Chemical in a strong transformation, listen to Weidong Yuan share how to open up a new chapter in the API field.

Medicilon AI Drug Discovery Service Platform: An Efficient Booster for New Drug Development

Medicilon's AI technology service platform can provide protein structure prediction and simulation, binding site discovery, information extraction and cleansing, as well as customized project database construction, meeting diverse needs of researchers.

Medicilon AI Drug Discovery Service Platform: An Efficient Booster for New Drug Development

Medicilon Interview - Smart Drug Development is Inevitable: Dr. Feng Ren Talks Fearless Advancements in AI Pharmaceuticals

Medicilon is honored to invite Dr. Feng Ren, the joint CEO and Chief Scientific Officer of Insilico Medicine, to discuss and interpret the developments and trends of AI in new drug research and development.

Medicilon Interview - Smart Drug Development is Inevitable: Dr. Feng Ren Talks Fearless Advancements in AI Pharmaceuticals

Medicilon Interview - Sungening Biological has successfully authorized collaboration, and Dr. Chenguang Yuan elaborated on the market trends and innovations in antifungal drugs

Sungening Biological (Sungening) has successfully obtained an implicit permission from the National Medical Products Administration for clinical trials (acceptance number: CXHL2400203) for its first innovative drug, SG1001.

Medicilon Interview - Sungening Biological has successfully authorized collaboration, and Dr. Chenguang Yuan elaborated on the market trends and innovations in antifungal drugs

Medicilon Nucleic Acid Drug Preclinical Evaluation Services

Medicilon has accumulated profound accumulation in the field of nucleic acid drug research and development, and has comprehensive preclinical research capabilities: strong research strength in drug synthesis, modification and delivery systems to ensure drug stability and activity.

Medicilon Nucleic Acid Drug Preclinical Evaluation Services

Medicilon honored with the 'Best Client Satisfaction Pharmaceutical CRO' at the 2024 VBEF."

On May 9th, the "2024 Top 100 Future Healthcare" series rankings were officially unveiled. Medicilon successfully made it onto the list and was awarded the "Best Client Satisfaction Pharmaceutical CRO" due to its outstanding market performance, human resources, knowledge resources, and essential partnership resources.

Medicilon honored with the 'Best Client Satisfaction Pharmaceutical CRO' at the 2024 VBEF."

Empowering API Quality Enhancement! Medicilon Received the 'Best Collaboration Award' from Jingye Medicine & Chemical Co., Ltd

Recently, Medicilon is honored to have received a thank-you letter from Jingye Medicine & Chemical Co., Ltd (Jingye Medicine) and was awarded the "Best Collaboration Award".

Empowering API Quality Enhancement! Medicilon Received the 'Best Collaboration Award' from Jingye Medicine & Chemical Co., Ltd

Winning for the third time in a row! Medicilon won the "Pharmaceutical Innovation Award - Top Ten Drug Innovation Service Institutions of the Year"

Medicilon USA Corp. (Medicilon) stood out with its cutting-edge innovative technology and excellent service capabilities, and won the "Pharmaceutical Innovation Award - Top Ten Drug Innovation Service Institutions of the Year".

Winning for the third time in a row! Medicilon won the "Pharmaceutical Innovation Award - Top Ten Drug Innovation Service Institutions of the Year"

prev
1
2
3
4
5
6
7
8
9
10
11
next

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy

-->